Insider · CIK 0001637852
John Bradley Schmieder
Files at MLAB (MESA LABORATORIES INC /CO/). First filing Nov 21, 2022, latest Jan 17, 2023.
In brief
John Bradley Schmieder files SEC Form 4 as director at MLAB (MESA LABORATORIES INC /CO/). Since Nov 21, 2022, John Bradley Schmieder has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.0M, the latest filed on Jan 17, 2023.
A track record needs three past buys with six months of prices behind them; John Bradley Schmieder has 0, so none is measured yet.
The newest scored trade: sold $301k of MLAB on Jan 13, 2023, filed Jan 17, 2023, scored 37 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MLAB: MESA LABORATORIES INC /CO/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | MESA LABORATORIES INC /CO/ | $301k 1,571 shares | -2% | +61% from low-37% from high | |
| 17Weak | MESA LABORATORIES INC /CO/ | $301k 1,571 shares | -2% | +61% from low-37% from high | |
| 32Weak | MLABsell MESA LABORATORIES INC /CO/ | $439k 2,500 shares | -3% | +52% from low-46% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | 7,000 0.13% of outstanding | $859k | Sep 13, 2023 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | MLAB MESA LABORATORIES INC /CO/ | MOption exercise Common Stock | +30 | $0.00 | $0 | 69,006 | Jun 16, 2023 |
| Jun 15, 2023 | MLAB MESA LABORATORIES INC /CO/ | MOption exercise Restricted Stock Unit - 1derivative | -30 | $0.00 | $0 | 0 | Jun 16, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | XIn-the-money exercise Common Stock | +571 | $72.02 | $41k | 69,547 | Jan 17, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | SOpen-market sale Common Stock10b5-1 | -1,571 | $191.31 | $301k | 68,976 | Jan 17, 2023 |
| Jan 13, 2013 | MLAB MESA LABORATORIES INC /CO/ | XIn-the-money exercise Common Stock | +1,000 | $122.66 | $123k | 70,547 | Jan 17, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | SOpen-market sale Common Stock | -1,571 | $191.31 | $301k | 68,976 | Jan 17, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | XIn-the-money exercise Non Qualified Stock Optionsderivative | -571 | $0.00 | $0 | 1,450 | Jan 17, 2023 |
| Jan 13, 2023 | MLAB MESA LABORATORIES INC /CO/ | XIn-the-money exercise Non Qualified Stock Optionderivative | -1,000 | $0.00 | $0 | 450 | Jan 17, 2023 |
| Nov 11, 2022 | MLAB MESA LABORATORIES INC /CO/ | SOpen-market sale Common Stock | -2,500 | $175.45 | $439k | 68,976 | Nov 21, 2022 |
Questions about John Bradley Schmieder
Answered from the filings on this page, as of the latest one.
Is John Bradley Schmieder buying or selling?
Not in the last 12 months. John Bradley Schmieder's latest open-market trade on SEC Form 4 was sold $301k of MLAB on Jan 13, 2023.
How did John Bradley Schmieder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and John Bradley Schmieder has 0.
Where does John Bradley Schmieder file Form 4?
John Bradley Schmieder has filed Form 4 at MLAB (MESA LABORATORIES INC /CO/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.